Skip to main content
. 2018 Mar 25;20(7):1632–1641. doi: 10.1111/dom.13273

Figure 1.

Figure 1

Overview of ODYSSEY studies included in this analysis. Abbreviations: LLT, lipid‐lowering therapy; Q2W, every 2 weeks. Additional non‐statin LLTs were not allowed. http://clinicaltrials.gov identifiers: ALTERNATIVE, NCT01709513; COMBO I, NCT01644175; COMBO II, NCT01644188; FH I, NCT01623115; FH II, NCT01709500; HIGH FH, NCT01617655; LONG TERM, NCT01507831; MONO, NCT01644474; OPTIONS I, NCT01730040; OPTIONS II, NCT01730053